,47 As COVID-19 is a respiratory disorder with similar pathological features and symptoms comparable to other severe pulmonary virus infections, it is reasonable to speculate that IL-22 may also serve to limit the severity of this illness. This evidence concerns the gene IL22 and COVID-19.